Thank you for sharing!

Your article was successfully shared with the contacts you provided.
How Ambien maker Sanofi responded on Twitter to Roseanne Barr, who name-dropped the drug in responding to criticism about an offensive tweet.

On Tuesday, as the actor Roseanne Barr grappled with the public outcry over an offensive tweet that drove ABC to cancel her eponymously named show, she returned to Twitter to apologize and offer excuses. It was Memorial Day, she said. It was early in the morning. “I was ambien tweeting,” Barr told her followers.

C. Ryan Barber

C. Ryan Barber, based in Washington, covers government affairs and regulatory compliance. Contact him at cbarber@alm.com. On Twitter: @cryanbarber

More from this author ›

Lean Adviser Legal

Think Lean Daily Message

"Law firms are rightly afraid of having their bills challenged or, worse still, being sued by clients. They also have numerous safety related processes. These include client vetting, conflict checks, and of course training and supervision of lawyers. But the ultimate safety measure is doing the work effectively, efficiently, and transparently."

Learn More

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.